Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/antikoagulation-bei-vorhofflimmern-jM6B7bwFmU
References (30)
-
U Wiegand (2010)
Antikoagulationsmanagement bei Schrittmacher-/ICD-ImplantationMed Report, 34
-
P. Pasic, Dr. Bauer, P. Hetzer (2001)
Marfan-Syndrom und HerzklappenerkrankungenZeitschrift für Kardiologie, 90
-
R. Pisters, D. Lane, R. Nieuwlaat, H. Crijns, G. Lip (2012)
Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey -
H. Hoffmeister, C. Bode, H. Darius, K. Huber, K. Rybak, S. Silber (2010)
Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen ErkrankungenDer Kardiologe, 4
-
V. Fuster, L. Rydén, Davis Cannom, H. Crijns, A. Curtis, K. Ellenbogen, J. Halperin, J. Heuzey, G. Kay, James Lowe, S. Olsson, E. Prystowsky, J. Tamargo, S. Wann, S. Priori, J. Blanc, A. Budaj, A. Camm, V. Dean, Jaap Deckers, Catherine Despres, K. Dickstein, J. Lekakis, K. Mcgregor, M. Metra, J. Morais, A. Osterspey, J. Zamorano, Sidney Smith, A. Jacobs, C. Adams, Jeffery Anderson, E. Antman, S. Hunt, Rick Nishimura, J. Ornato, R. Page, B. Riegel (2006)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing CommittEuropean heart journal, 27 16
-
S. Olsson, J. Halperin (2005)
Prevention of Stroke in Patients with Atrial FibrillationSeminars in Vascular Medicine, 5
-
R. Hart, O. Benavente, R. Mcbride, L. Pearce (1999)
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial FibrillationAnnals of Internal Medicine, 131
-
P. Wolf, R. Abbott, W. Kannel (1991)
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 22 8
-
R. Sørensen, M. Hansen, S. Abildstrom, A. Hvelplund, C. Andersson, C. Jørgensen, J. Madsen, P. Hansen, L. Køber, C. Torp-Pedersen, G. Gislason (2009)
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry dataThe Lancet, 374
-
J. Tolosana, P. Berne, L. Mont, M. Heras, A. Berruezo, J. Monteagudo, D. Tamborero, B. Benito, J. Brugada (2009)
Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trialEuropean Heart Journal, 30
-
V Fuster, LE Ryden, DS Cannom, HJ Crijns, AB Curtis, KA Ellenbogen, JL Halperin, JY Heuzey, GN Kay, JE Lowe, SB Olsson, EN Prystowsky, JL Tamargo, S Wann (2006)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation – executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)Eur Heart J, 27
-
R. Rossini, G. Musumeci, C. Lettieri, M. Molfese, Laurian Mihalcsik, P. Mantovani, V. Sirbu, T. Bass, F. Rovere, A. Gavazzi, D. Angiolillo (2008)
Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.The American journal of cardiology, 102 12
-
RG Hart, O Benavente, R McBride (1999)
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysisAnn Intern Med, 131
-
U. Wiegand, D. Lejeune, F. Boguschewski, H. Bonnemeier, F. Eberhardt, H. Schunkert, F. Bode (2004)
Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.Chest, 126 4
-
SH Hohnloser, GZ Duray, U Baber, JL Halperin (2008)
Prevention of stroke in patients with atrial fibrillation: current strategies and future directionsEur Heart J, 10
-
C. Hart, D. Hole, G. Smith (2001)
Are Two Really Better Than One?: Empirical Examination of Repeat Blood Pressure Measurements and Stroke Risk in the Renfrew/Paisley and Collaborative StudiesStroke: Journal of the American Heart Association, 32
-
GYH Lip, K Huber, F Andreotti, H Arnesen, JK Airaksinen, T Cuisset, P Kirchhof, F Marin (2010)
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary – a Consensus Document of the European Society of Cardiology Working Group of Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Eur Heart J, 31
-
S Vetter, HM Ullmann, G Lauke, H Volkmann (2001)
Besonderheiten der Thromboembolieprophylaxe bei betagten Patienten mit VorhofflimmernZ Kardiol, 90
-
HM Hoffmeister, C Bode, H Darius, K Huber, K Rybak, S Silber (2010)
Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen Erkrankungen. PositionspapierKardiologe, 4
-
S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, S. Yusuf (2006)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 367
-
John Wright, C. Bradley, T. Sheldon, R. Lilford (2006)
Trial by media: dangers of misinterpretation of medical statisticsThe Lancet, 367
-
R. Hart, J. Halperin (2001)
Atrial fibrillation and stroke : concepts and controversies.Stroke, 32 3
-
G. Lip, K. Huber, F. Andreotti, H. Arnesen, J. Airaksinen, T. Cuisset, P. Kirchhof, F. Marín (2010)
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) aEuropean heart journal, 31 11
-
S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P. Reilly, E. Themeles, Jeanne Varrone, Susan Wang, M. Alings, D. Xavier, Jun Zhu, R. Diaz, B. Lewis, H. Darius, H. Diener, C. Joyner, L. Wallentin (2009)
Dabigatran versus warfarin in patients with atrial fibrillation.The New England journal of medicine, 361 12
-
S. Connolly, J. Pogue, R. Hart, S. Hohnloser, M. Pfeffer, S. Chrolavicius, S. Yusuf (2009)
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.The New England journal of medicine, 360 20
-
T. Lewalter, J. Tebbenjohanns, T. Wichter, M. Antz, C. Geller, K. Seidl, D. Gulba, F. Röhrig, S. Willems (2008)
Kommentar zu „ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation – executive summary“Der Kardiologe, 2
-
A. Turpie (2007)
New oral anticoagulants in atrial fibrillation.European heart journal, 29 2
-
A. Camm, P. Kirchhof, G. Lip, U. Schotten, I. Savelieva, S. Ernst, I. Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. Caterina, J. Sutter, A. Goette, B. Gorenek, M. Heldal, Stefan Hohloser, P. Kolh, J. Heuzey, P. Ponikowski, F. Rutten (2010)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).European heart journal, 31 19
-
R. Investigators (2010)
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.American heart journal, 159 3
-
B. Leithäuser, F. Kasch, T. Broemel, J.-W. Park (2010)
Persistierender linksatrialer Thrombus bei Vorhofflimmern unter oraler AntikoagulationHerz, 35
- Publisher
- Springer Journals
- Copyright
- Copyright © 2011 by Springer-Verlag
- Subject
- Medicine & Public Health; Internal Medicine; Cardiology; Diagnostic Radiology; Cardiac Surgery; Angiology
- ISSN
- 1861-0706
- eISSN
- 1861-0714
- DOI
- 10.1007/s11789-011-0022-6
- pmid
- 22528179
- Publisher site
- See Article on Publisher Site
Abstract
Die mit dem Vorhofflimmern verbundene erhöhte Morbidität und Mortalität ist in erster Linie auf thromboembolisch verursachte ischämische Schlaganfälle zurückzuführen. Die Prävention von thromboembolischen Komplikationen ist deshalb ein wesentlicher Bestandteil der Therapie des Vorhofflimmerns. Die optimale antithrombotische Strategie wird einerseits durch das thromboembolische Risiko bestimmt, das durch verschiedene Stratifikationsschemata determiniert werden kann. Andererseits beeinflusst das Blutungsrisiko die Wahl der antithrombotischen Therapie. Die Problematik der Nutzen-Risiko-Kalkulation ist dadurch gekennzeichnet, dass die Prädiktoren sowohl für Thromboembolien als auch für Blutungen sehr ähnlich, zum Teil sogar identisch sind.
Journal
Clinical Research in Cardiology Supplements – Springer Journals
Published: Mar 10, 2011